Novoheart is a groundbreaking stem cell biotechnology company that has created miniature living human heart pumps for drug discovery. It is the only company in the world that has engineered such prototypes, which can revolutionize drug development, saving both time and money. Novoheart's bio-artificial human heart constructs are made using state-of-the-art and proprietary stem cell and bioengineering approaches, which are utilized by global pharmaceutical and biotech companies for preclinical testing. The company has offices and laboratories in the United States, Canada, and Hong Kong.